Citius Share Price

Citius Share Price

NASDAQ: CTOR | Micro Cap | Healthcare
$0.56
-$0.01 (-2.18%) Last updated on 18 Nov, 2026 | 20:52 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Citius Stock Performance

Open
N/A
Prev. Close
$0.57
Circuit Range
N/A
Day Range
N/A
Year Range
$0.49 - $1.80
Volume
N/A
Average Traded
N/A

Citius Share Price Chart

Line chart of the Citius price trend over the selected period. The price fell overall, ranging from 0.56 to 0.56, ending at 0.56.
$0.00$0.00
L
Show Current Price
H

Citius Stock Fundamentals & Key Indicators

Market Cap
$41.06M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.44
Revenue (TTM)
$0.00
Return On Equity (TTM)
-114.06%
Profit Margin
N/A
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-78.40%

Citius Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$3.94$1.67$1.49
Net Profit-$5.00-$5.53-$26.61-$8.92
Net Profit MarginN/A-140.36%-1593.41%-598.66%
Income ChangeN/A-10.60%-381.19%66.48%

Citius Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$21.15-$24.76
Net Profit MarginN/AN/A
Income ChangeN/A-17.07%

Citius Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets73.473.4
Current Assets27.5410.97
Total Assets100.9484.37
Non Current Liabilities6.595.53
Current Liabilities49.4932.7
Total Liabilities56.0838.23
Shareholders' Equity44.8746.14

Citius Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-5.490.13
Investing-5.75-5.0
Financing15.174.87

About Citius

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Citius Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.61
$0.57
+13.94%
Oct 2026
$1.07
$0.50
-50.78%
Sep 2026
$0.74
$1.02
+34.21%
Aug 2026
$0.68
$0.76
+37.18%
Jul 2026
$0.71
$0.55
-18.77%
Jun 2026
$0.79
$0.68
-15.80%
May 2026
$0.89
$0.81
-8.99%
Apr 2026
$0.61
$0.89
+43.78%
Mar 2026
$1.08
$0.62
-42.95%
Feb 2026
$1.04
$1.08
+0.46%
Jan 2026
$1.01
$1.08
+10.32%
Dec 2025
$1.48
$0.98
-27.48%

Citius Share Price FAQs